Edwards Lifesciences (EW) Offers Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cowen Reiterates Outperform on Edwards Lifesciences (EW)
December 10, 2018 8:18 AM ESTCowen analyst, Joshua Jennings, reiterated an Outperform rating and $190.00 price target on Edwards Lifesciences (NYSE: EW). Jennings views the 4Q18 setup favorably and expects EW to accelerate TAVR sales growth in 2019. Cowen thinks last weeks investor conference justifies bullishness about the growth... More
Edwards Lifesciences (EW) PT Raised to $175 at RBC Capital
December 6, 2018 7:15 AM ESTRBC Capital analyst Glenn Novarro raised the price target on Edwards Lifesciences (NYSE: EW) to $175.00 (from $153.00) while maintaining a Outperform rating.
The firm is increasing EPS estimates for 2019 and 2020 on the basis of higher gross margin and lower tax rate assumptions.
... More


